DR. DAVID JAMES PIZZUTI, M.D.
Osteopathic Medicine at Santa Rita Ave, Menlo Park, CA
License number
California G88102
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California 25MA05404700
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California 152564
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
470 Santa Rita Ave, Menlo Park, CA 94025
Phone
(650) 269-7626
(650) 473-6902 (Fax)
(650) 473-6902 (Fax)
Personal information
See more information about DAVID JAMES PIZZUTI at radaris.comName
Address
Phone
470 Santa Rita Ave, Menlo Park, CA 94025
8141 Turner Dr, Granite Bay, CA 95746
725 Olive St, Menlo Park, CA 94025
Palo Alto, CA
6060 Kingwood Cir, Rocklin, CA 95677
Professional information
Method For Treating A Pulmonary Hypertension Condition Without Companion Diagnosis
US Patent:
2013022, Aug 29, 2013
Filed:
Aug 9, 2012
Appl. No.:
13/571039
Inventors:
Hunter Campbell Gillies - El Granada CA, US
Tobias Peschel - Redwood City CA, US
David J. Pizzuti - Menlo Park CA, US
Tobias Peschel - Redwood City CA, US
David J. Pizzuti - Menlo Park CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
A61K 31/513, A61K 31/519, A61P 9/12
US Classification:
514257, 514274
Abstract:
There is provided a method for treating pulmonary hypertension in a subject, comprising: administering to the subject in need thereof a daily dose of ambrisentan from 1 mg to about 15 mg, wherein the method is carried out without drug labeling instruction to monitor liver aminotransferase levels during ambrisentan treatment.
Method For Treating Pulmonary Arterial Hypertension In A Patient Not Having Idiopathic Pulmonary Fibrosis
US Patent:
2013022, Aug 29, 2013
Filed:
Mar 14, 2013
Appl. No.:
13/830211
Inventors:
Gilead Sciences, Inc. - , US
Tobias Peschel - Redwood City CA, US
David J. Pizzuti - Menlo Park CA, US
Tobias Peschel - Redwood City CA, US
David J. Pizzuti - Menlo Park CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
A61K 31/505, A61K 45/06
US Classification:
514250, 514274
Abstract:
There is provided a method of treating pulmonary hypertension in a patient in need thereof, said method comprising: administering a therapeutically effective amount of ambrisentan to the patient with pulmonary arterial hypertension, wherein the patient has been determined not to have idiopathic pulmonary fibrosis.
Method For Treating A Pulmonary Hypertension Condition Without Companion Diagnosis
US Patent:
2013022, Aug 29, 2013
Filed:
Jun 28, 2012
Appl. No.:
13/536001
Inventors:
Hunter Campbell Gillies - El Granada CA, US
Tobias Peschel - Redwood City CA, US
David J. Pizzuti - Menlo Park CA, US
Tobias Peschel - Redwood City CA, US
David J. Pizzuti - Menlo Park CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
A61K 31/505, A61P 7/02, A61K 31/53, A61K 31/519, A61P 9/12, A61K 31/5585, A61P 7/10, A61K 33/00
US Classification:
424613, 514274, 514250, 5142621, 514243
Abstract:
There is provided a method for treating pulmonary hypertension in a subject, comprising: administering to the subject in need thereof a daily dose of ambrisentan from 1 mg to about 15 mg, wherein the method is carried out without drug labeling instruction to monitor liver aminotransferase levels during ambrisentan treatment.
Method For Treating A Pulmonary Hypertension Condition Without Companion Diagnosis
US Patent:
2014003, Jan 30, 2014
Filed:
Jul 30, 2013
Appl. No.:
13/954779
Inventors:
Hunter Campbell Gillies - El Granada CA, US
Tobias Peschel - Redwood City CA, US
David J. Pizzuti - Menlo Park CA, US
Tobias Peschel - Redwood City CA, US
David J. Pizzuti - Menlo Park CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
A61K 31/505, A61K 31/4985, A61K 45/06
US Classification:
424613, 514274, 514250
Abstract:
There is provided a method for treating pulmonary hypertension in a subject, comprising: administering to the subject in need thereof a daily dose of ambrisentan from 1 mg to about 15 mg, wherein the method is carried out without drug labeling instruction to monitor liver aminotransferase levels during ambrisentan treatment.
Dr. David J Pizzuti, Menlo Park CA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
470 Santa Rita Ave, Menlo Park 94025
(650) 473-6902 (Fax)
(650) 473-6902 (Fax)
Languages:
English
Dr. David J Pizzuti, Menlo Park CA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
470 Santa Rita Ave, Menlo Park 94025
(650) 269-7626 (Phone), (650) 473-6902 (Fax)
333 Lakeside Dr, Foster City 94404
(650) 269-7626 (Phone), (650) 473-6902 (Fax)
333 Lakeside Dr, Foster City 94404
Certifications:
Internal Medicine, 1985
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
New York University
Graduated: 1981
Bellevue Hospital Center
Montefiore Medical Center-Moses Division
New York University
Graduated: 1981
Bellevue Hospital Center
Montefiore Medical Center-Moses Division